Xeris Biopharma: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Wednesday reported a loss of $13.4 million in its fourth quarter.

The Chicago-based company said it had a loss of 10 cents per share.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.

The company posted revenue of $44.4 million in the period.

For the year, the company reported a loss of $62.3 million, or 45 cents per share. Revenue was reported as $163.9 million.

Xeris Biopharma expects full-year revenue in the range of $170 million to $200 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS

Advertisement

Recommended Stories